<bill session="116" type="s" number="3116" updated="2022-10-28T01:46:13Z">
  <state datetime="2019-12-19">REFERRED</state>
  <status>
    <introduced datetime="2019-12-19"/>
  </status>
  <introduced datetime="2019-12-19"/>
  <titles>
    <title type="display">Ending the Diagnostic Odyssey Act of 2019</title>
    <title type="short" as="introduced">Ending the Diagnostic Odyssey Act of 2019</title>
    <title type="official" as="introduced">A bill to enable States to better provide access to whole genome sequencing clinical services for certain undiagnosed children under the Medicaid program, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="C001035"/>
  <cosponsors>
    <cosponsor bioguide_id="J000300" joined="2019-12-19"/>
    <cosponsor bioguide_id="M001197" joined="2019-12-19"/>
    <cosponsor bioguide_id="M000639" joined="2019-12-19"/>
    <cosponsor bioguide_id="S001203" joined="2020-03-05"/>
  </cosponsors>
  <actions>
    <action datetime="2019-12-19">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2019-12-19" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
      <reference ref="CR S7211" label="Sponsor introductory remarks on measure"/>
    </action>
  </actions>
  <committees>
    <committee code="SSFI" name="Senate Finance" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="116" type="h" number="4144" relation="unknown"/>
    <bill session="116" type="h" number="4393" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Adoption and foster care"/>
    <term name="Cell biology and embryology"/>
    <term name="Child health"/>
    <term name="Emergency medical services and trauma care"/>
    <term name="Genetics"/>
    <term name="Health care costs and insurance"/>
    <term name="Health care coverage and access"/>
    <term name="Health care quality"/>
    <term name="Health programs administration and funding"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Hospital care"/>
    <term name="Medicaid"/>
    <term name="Medical tests and diagnostic methods"/>
    <term name="State and local government operations"/>
  </subjects>
  <amendments/>
  <summary date="2020-02-10T22:37:03Z" status="Introduced in Senate">Ending the Diagnostic Odyssey Act of 2019

This bill allows state Medicaid programs to cover whole genome sequencing services for certain individuals.

Specifically, states may cover such services for individuals under the age of 21 (or a lower age, if the state chooses) and for former foster youth under the age of 26 who (1) have been referred or admitted to an intensive care unit or seen by a medical specialist for a suspected genetic or undiagnosed disease, or (2) are suspected by a medical specialist to have a neonatal- or pediatric-onset genetic disease.

The Centers for Medicare &amp; Medicaid Services may award grants to assist states in developing plans to cover such services.</summary>
</bill>
